about
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cellsImidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysisThe nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cellsProteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humansInterspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinA fully dissociated compound of plant origin for inflammatory gene repressionCatalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in micePPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaBS 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.PPARβ/δ activation induces enteroendocrine L cell GLP-1 production.The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism.Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα.Paullinia pinnata extracts rich in polyphenols promote vascular relaxation via endothelium-dependent mechanisms.4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations.Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions.PPARalpha regulates the production of serum Vanin-1 by liver.Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice.PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance.DHA-derived oxylipins, neuroprostanes and protectins, differentially and dose-dependently modulate the inflammatory response in human macrophages: Putative mechanisms through PPAR activation.The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosisSynthesis and evaluation of new polyenic compounds as potential PPARs modulatorsStudies towards the conception of new selective PPARβ/δ ligands
P50
Q27324038-DC4BD40A-E873-4B4D-9518-0510B952A7AAQ27683399-30C49995-33B8-4111-9818-7A68FDED4E78Q33636639-52996A10-543A-4643-A9C0-81EC28D2876DQ33815655-BAA0F6D0-9257-4F91-AF70-1B1280C5EF5AQ33877800-3361C0A7-DD50-4F20-81D3-34C04F44F683Q34115914-221F463B-7A1A-49BE-88F0-B2DB10026166Q36087916-03225713-8437-4FDD-863E-2AD3C7C7CC92Q37183113-9D2DFC82-B2DD-4E5A-A238-751AAE684864Q38299115-7E4CC048-7102-44BA-8DFD-4EC36DA5620AQ38320967-8CBAA4D8-0898-4996-8E2D-1B0BA675DB73Q38337483-08D6F8C8-5660-43C7-84BD-E537B241618AQ39346744-C6102E0D-738E-40CE-B16F-B6CB9C08E8D7Q39439403-D1330FFA-9CDC-4FB2-BEAC-D6741445D2FFQ39622309-E1ADC6F9-EDCD-4B6C-ADD2-FD7B9B1EB144Q39859350-19FB5D4F-5FF8-4071-92AE-4ADE15DF855EQ42807756-3952F840-7AA6-42F1-8AB5-D86669FB715EQ45054466-A2ECA84D-16E1-4AD4-A089-7CD14908A9CBQ45775414-B707FEC6-CEAF-43C6-B1BE-6B0F36C22D9DQ46212721-523DB1E0-4209-420A-8D24-02B3F45D8383Q46322918-D16AD413-D754-49A8-9B2B-6B92E3D6C9BAQ46580812-5C9347C1-E46F-4F71-AE6F-12A1722C93D4Q48270505-2734B4CA-4354-4CA9-9B80-11A3AB323C09Q51252957-713EF2A9-0634-428A-91A6-4774100963E2Q51517158-F9A0A840-59AC-4C2B-88DA-9BB186002ACEQ57243988-E316D4E3-0486-4DDA-A2E0-812240F6171EQ57244069-D11F0354-5BF3-4274-91A8-0800188DB024Q57244232-9C6AA754-F881-4666-8D37-1A7FDB3937BF
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nathalie Hennuyer
@ast
Nathalie Hennuyer
@en
Nathalie Hennuyer
@es
Nathalie Hennuyer
@nl
type
label
Nathalie Hennuyer
@ast
Nathalie Hennuyer
@en
Nathalie Hennuyer
@es
Nathalie Hennuyer
@nl
prefLabel
Nathalie Hennuyer
@ast
Nathalie Hennuyer
@en
Nathalie Hennuyer
@es
Nathalie Hennuyer
@nl
P106
P21
P31
P496
0000-0003-0303-7258